Wire · opportunities
Late-breaking data for Abbott's TactiFlex™ Duo Ablation Catheter reveal positive outcomes ...
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 31 August 2026 · Fusion42 review
Abbott's TactiFlex Duo Ablation Catheter, combining pulsed field ablation and radiofrequency energy, demonstrated high safety and effectiveness in treating complex atrial fibrillation cases as presented at the European Society of Cardiology Congress 2026 with supportive 12-month clinical data.
This Wire brief sits within Fusion42's coverage of Medtech, and 3 sources have reported it between 31 Aug 2026 and 8 Sep 2026.
◆ ◆ The Wire takeaway
You have a clearer path to market in the U.S. as Abbott's catheter nears FDA approval with strong clinical backing. Accelerate engagement with electrophysiology specialists now while confidence in ablation therapy rises.
◆ Coverage
3 sources · first reported 31 Aug 2026 · latest 8 Sep 2026
◆ Related on Wire
◆ Topics